Abstract
This is a general review of currently available antimalarial drugs, these compounds are gathered according with its chemical structure and the biological targets. A great number of these new antimalarial agents are now moving actively in the pipeline from basic science to clinical studies.
Keywords: antimalarial drugs, development of new antimalarial drugs, quinine andchloroquine analogues, artemisinin and its analogues
Current Topics in Medicinal Chemistry
Title: Chemotherapeutic Agents Against Malaria: What Next After Chloroquine?
Volume: 2 Issue: 11
Author(s): Jose N. Dominguez
Affiliation:
Keywords: antimalarial drugs, development of new antimalarial drugs, quinine andchloroquine analogues, artemisinin and its analogues
Abstract: This is a general review of currently available antimalarial drugs, these compounds are gathered according with its chemical structure and the biological targets. A great number of these new antimalarial agents are now moving actively in the pipeline from basic science to clinical studies.
Export Options
About this article
Cite this article as:
Dominguez N. Jose, Chemotherapeutic Agents Against Malaria: What Next After Chloroquine?, Current Topics in Medicinal Chemistry 2002; 2 (11) . https://dx.doi.org/10.2174/1568026023392986
DOI https://dx.doi.org/10.2174/1568026023392986 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery
Current Topics in Medicinal Chemistry Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders
Current Gene Therapy New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design Breast Cancer Image Classification: A Review
Current Medical Imaging Composition and Potential Health Benefits of Pomegranate: A Review
Current Pharmaceutical Design Implications for CNS Repair of Redox Modulation of Cell Survival, Division and Differentiation
Current Alzheimer Research Nanostructures for Treating Musculoskeletal Conditions
Current Bioactive Compounds The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia
Current Medicinal Chemistry HIV-1 Associated Topoisomerase IIβ Kinase: A Potential Pharmacological Target for Viral Replication
Current Pharmaceutical Design Computational Prediction of RNA Editing Sites: Successes and Challenges Ahead
Current Bioinformatics Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design Expression and Functions of Vasoactive Substances Regulated by Hypoxia-Inducible Factor-1 in Chronic Hypoxemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Identifying Risk Factors for Clinically Significant Diabetic Macula Edema in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review
Current Molecular Pharmacology Advances in Hydrogels Applied to Degenerative Diseases
Current Pharmaceutical Design Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
Current Drug Targets Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer
Current Pharmaceutical Design Carbohydrate-Based Recognition Systems in Primary Open Angle Glaucoma
Current Organic Chemistry Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Recent Patents on Cardiovascular Drug Discovery